Trials / Unknown
UnknownNCT04512859
Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage
Effect of Stellate Ganglion Block on Cerebral Vasospasm in Patients With Emergency Aneurysmal Subarachnoid Hemorrhage
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Beijing Tiantan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To investigate whether the stellate ganglion block is helpful in relieving cerebral vasospasm during aneurysmal coil embolism surgery. The effect was assessed by Transcranial Doppler (TCD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Stellate Ganglion Block | Stellate ganglion block under ultra-guide will be administered using 0.25% ropivacaine 10mL |
| PROCEDURE | Placebo | Stellate ganglion block under ultra-guide will be administered using 0.9% saline 10mL |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2020-08-14
- Last updated
- 2020-09-09
Source: ClinicalTrials.gov record NCT04512859. Inclusion in this directory is not an endorsement.